MCID: BLL003
MIFTS: 48

Bell's Palsy malady

Categories: Rare diseases, Neuronal diseases

Aliases & Classifications for Bell's Palsy

About this section

Aliases & Descriptions for Bell's Palsy:

Name: Bell's Palsy 11 48 49 38 13
Bell Palsy 11 48 39 68
Facial Paralysis 48 68
Facial Cranial Nerve Paralysis 48
Idiopathic Facial Palsy 48
 
Refrigeration Palsy 48
Facial Nerve Palsy 48
Antoni's Palsy 48
Bell's Palsy 11
Facial Palsy 48

Classifications:



External Ids:

Disease Ontology11 DOID:12506
ICD1030 G51.0
ICD9CM32 351.0
MeSH39 D020330

Summaries for Bell's Palsy

About this section
NINDS:49 Bell's palsy is a form of temporary facial paralysis resulting from damage or trauma to the 7th cranial nerve, one of the facial nerves.  It is the most common cause of facial paralysis. Generally, Bell's palsy affects only one side of the face, however, in rare cases, it can affect both sides.  Symptoms usually begin suddenly and reach their peak within 72 hours, and can range in severity from mild weakness to total paralysis.  Symptoms vary among individuals and include sudden weakness on one side of the face, drooping eyelid or corner of the mouth, drooling, dry eye or mouth, altered taste, and excessive tearing in the eye. Bell’s palsy can cause significant facial distortion. The exact cause of Bell's palsy isn't known, but many scientists believe that reactivation of a dormant viral infection can cause the facial nerve to swell and becomes inflamed.  Several other conditions can cause facial paralysis that might be diagnosed as Bell's palsy.

MalaCards based summary: Bell's Palsy, also known as bell palsy, is related to recurrent peripheral facial palsy and deafness, conductive stapedial, with ear malformation and facial palsy, and has symptoms including hemiplegia, ophthalmoplegia and oral manifestations. An important gene associated with Bell's Palsy is HS1BP3 (HCLS1 Binding Protein 3), and among its related pathways are Calcineurin-regulated NFAT-dependent transcription in lymphocytes and IgA-Producing B Cells in the Intestine. The drugs scopolamine hydrobromide and scopolamine have been mentioned in the context of this disorder. Affiliated tissues include eye, testes and neutrophil.

NIH Rare Diseases:48 Bell's palsy is a form of temporary facial paralysis which results from damage or trauma to one of the facial nerves. this disorder is characterized by the sudden onset of facial paralysis that often affects just one side and can cause significant facial distortion. symptoms vary, but may include twitching, weakness, drooping eyelid or corner of the mouth, drooling, dry eye or mouth, impairment of taste, and excessive tearing in the eye. while the exact cause is unknown, many researchers believe that a virus may lead to swelling of the 7th cranial nerve. steroids, such as prednisone, may reduce the inflammation and swelling. other medications used to treat bell's palsy include acyclovir (to fight viral infections) and aspirin, acetaminophen, or ibuprofen (to relieve pain). physical therapy, facial massage and acupuncture have also been used. last updated: 1/22/2016

MedlinePlus:38 Bell's palsy is the most common cause of facial paralysis. it usually affects just one side of the face. symptoms appear suddenly and are at their worst about 48 hours after they start. they can range from mild to severe and include twitching weakness paralysis drooping eyelid or corner of mouth drooling dry eye or mouth excessive tearing in the eye impaired ability to taste scientists think that a viral infection makes the facial nerve swell or become inflamed. you are most likely to get bell's palsy if you are pregnant, diabetic or sick with a cold or flu. three out of four patients improve without treatment. with or without treatment, most people begin to get better within 2 weeks and recover completely within 3 to 6 months. nih: national institute of neurological disorders and stroke

Disease Ontology:11 A facial paralysis resulting from dysfunction in the cranial nerve VII (facial nerve).

Wikipedia:71 Bell\'s palsy is a type of facial paralysis that results in an inability to control the facial muscles... more...

Related Diseases for Bell's Palsy

About this section

Diseases related to Bell's Palsy via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 40)
idRelated DiseaseScoreTop Affiliating Genes
1recurrent peripheral facial palsy12.0
2deafness, conductive stapedial, with ear malformation and facial palsy11.9
3facial paralysis11.5
4van buchem disease11.3
5geniculate herpes zoster11.3
6sclerosteosis 210.8
7sclerosteosis 110.8
8infundibulocystic basal cell carcinoma10.1CD40LG, MX1
9vaginal mullerian papilloma10.1CD40LG, MX1
10lipomatosis, multiple symmetric10.1CD40LG, MX1
11pseudohypoaldosteronism, type iic10.1CD40LG, IL2RA
12benign mediastinal neurilemmoma10.1DEFA1, DEFA3
13lagophthalmos10.1
14glomangiosarcoma10.1CD40LG, PMP22
15powassan encephalitis10.1CD40LG, MX1
16central nervous system origin vertigo10.1CD40LG, IL2RA
17sarcomatoid transitional cell carcinoma10.1DEFA1, DEFA3
18female breast nipple and areola cancer10.1CD40LG, PMP22
19squamous cell papilloma of skin10.1CD40LG, IL2RA
20facial palsy, familial recurrent peripheral10.1
21immunoglobulin g deficiency10.1CD40LG, IL2RA
22myiasis10.0CD40LG, IL2RA
23heart conduction disease10.0CD40LG, IL2RA
24anterior foramen magnum meningioma10.0CD40LG, IL2RA
25advanced sleep phase syndrome, familial, 110.0CD40LG, IL2RA, MX1
26bone fracture10.0
27choreatic disease9.9CD40LG, PMP22
28relapsing-remitting multiple sclerosis9.9CD40LG, DEFA1, DEFA3
29trachoma9.9CD40LG, MX1
30melkersson-rosenthal syndrome9.9
31chickenpox9.9
32otitis externa9.9
33benign paroxysmal positional nystagmus9.7CD40LG, HOXB1, LIPN
34cardiovascular cancer9.7CD40LG, HOXB1, LIPN
35essential tremor9.7
36otitis media9.7
37lyme disease9.7
38herpes simplex9.7
39tremor9.7
40trichuriasis8.8CD40LG, DEFA1, DEFA3, HOXB1, HS1BP3, IL2RA

Graphical network of the top 20 diseases related to Bell's Palsy:



Diseases related to bell's palsy

Symptoms & Phenotypes for Bell's Palsy

About this section

UMLS symptoms related to Bell's Palsy:


hemiplegia, ophthalmoplegia, oral manifestations, sciatica, facial paresis, facial palsy, upper motor neuron, facial palsy, lower motor neuron, hemifacial paralysis, back pain, headache, flaccid muscle tone, pain, seizures, syncope, tremor, chronic pain, muscle weakness, vertigo/dizziness, generalized muscle weakness, sleeplessness

Drugs & Therapeutics for Bell's Palsy

About this section

Drugs for Bell's Palsy (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 51)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Prednisoloneapproved, vet_approvedPhase 4, Phase 3119350-24-85755
Synonyms:
(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
.DELTA.1-Cortisol
.DELTA.1-Dehydrocortisol
.DELTA.1-Dehydrohydrocortisone
.DELTA.1-Hydrocortisone
.delta.-Cortef
.delta.-Stab
1,2-Dehydrohydrocortisone
1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione
1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol
1-Dehydrocortisol
1-Dehydrohydrocortisone
3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene
46656_FLUKA
46656_RIEDEL
50-24-8
58201-11-9
8056-11-9
AC-1773
AC1L1L2E
Ak-Pred
Ak-Tate
Alphadrol
Articulose-50
BPBio1_000164
BRD-K98039984-001-03-0
BRN 1354103
BSPBio_000148
Bio-0666
Bubbli-Pred
C07369
CCRIS 980
CHEBI:8378
CHEMBL131
CID5755
CO-Hydeltra
CPD000718761
Co-Hydeltra
Codelcortone
Cordrol
Cortalone
Cotogesic
Cotolone
D00472
D011239
DB00860
Decaprednil
Decortin H
Delcortol
Delta F
Delta(1)-dehydrohydrocortisone
Delta-Cortef
Delta-Cortef (TN)
Delta-Ef-Cortelan
Delta-Stab
Delta-stab
Deltacortenol
Deltacortril
Deltacortril Enteric
Deltahydrocortisone
Deltasolone
Deltisilone
Depo-Medrol
Derpo PD
Derpo Pd
Dexa-Cortidelt Hostacortin H
Dexa-Cortidelt hostacortin H
Di Adreson F
Di-Adreson F
Di-Adreson-F
Di-adreson F
DiAdresonF
Dicortol
Donisolone
Dydeltrone
EINECS 200-021-7
Eazolin D
Econopred
Econopred Plus
Erbacort
Erbasona
Estilsona
Fernisolone
Fernisolone P
Fernisolone-P
Flamasone
HMS1568H10
HMS2090J05
HSDB 3385
Hostacortin H
Hydeltra
Hydeltra-Tba
Hydeltrasol
Hydeltrone
Hydrodeltalone
Hydrodeltisone
Hydroretrocortin
Hydroretrocortine
I-Pred
Inflamase Forte
Inflamase Mild
K 1557
Key-Pred
Klismacort
LMST02030179
LS-7669
Lentosone
Lite Pred
M-Predrol
 
MLS001304083
MLS002154250
MLS002207037
Medrol
Medrol Acetate
Metacortandralone
Methylprednisolone Acetate
Meti-Derm
Meticortelone
Metreton
MolPort-002-507-147
NCGC00179649-01
NSC 9120
NSC9120
NSC9900
Neo-Delta-Cortef
Nisolone
Nor-Pred T.B.A.
Ocu-Pred
Ocu-Pred Forte
Ophtho-Tate
Orapred
P0152_SIGMA
P0637
P6004_SIGMA
PRDL
PRED-G
Panafcortelone
Paracortol
Paracotol
Pediapred
Poly-Pred
Precortalon
Precortancyl
Precortilon
Precortisyl
Pred Forte
Pred Mild
Predair
Predair A
Predair Forte
Predalone 50
Predalone T.B.A.
Predate
Predate Tba
Predate-50
Predcor-25
Predcor-50
Predcor-Tba
Predisolone Sodium Phosphate
Predne-Dome
Prednelan
Predni-Dome
Prednicen
Predniliderm
Predniretard
Prednis
Prednisolona
Prednisolona [INN-Spanish]
Prednisolone (JP15/USP/INN)
Prednisolone (anhydrous)
Prednisolone Acetate
Prednisolone Sodium Phosphate
Prednisolone Tebutate
Prednisolone [INN:BAN:JAN]
Prednisolonum
Prednisolonum [INN-Latin]
Predonin
Predonine
Prelone
Prenolone
Prestwick0_000274
Prestwick1_000274
Prestwick2_000274
Prestwick3_000274
Prestwick_404
Rolisone
S1737_Selleck
SAM002264639
SMR000718761
SPBio_002367
Scherisolon
Solone
Steran
Sterane
Sterolone
Supercortisol
UNII-9PHQ9Y1OLM
Ulacort
Ultra Pred
Ultracorten H
Ultracortene H
Ultracortene-H
Ultracortene-Hydrogen
Ultracortene-hydrogen
ZINC03833821
component of Ataraxoid
component of K-Predne-Dome
delta(1)-Cortisol
delta(1)-Dehydrocortisol
delta(1)-Dehydrohydrocortisone
delta(1)-Hydrocortisone
delta(sup 1)-Cortisol
delta(sup 1)-Dehydrocortisol
delta(sup 1)-Dehydrohydrocortisone
delta(sup 1)-Hydrocortisone
delta-dehydrocortisol
delta-dehydrohydrocortisone
delta-hydrocortisone
prednisolone
2
Methylprednisoloneapproved, vet_approvedPhase 4, Phase 3119383-43-26741
Synonyms:
(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
(6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione
.DELTA.1-6.alpha.-Methylhydrocortisone
1-Dehydro-6alpha-methylhydrocortisone
1-dehydro-6alpha-Methylhydrocortisone
1-dehydro-6α-methylhydrocortisone
11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione
11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
121673-01-6
4-08-00-03498 (Beilstein Handbook Reference)
46436_FLUKA
46436_RIEDEL
570-35-4
6 Methylprednisolone
6-Methylprednisolone
6-alpha-Methylprednisolone
6.alpha.-Methylprednisolone
6923-42-8
6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione
6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
6alpha-Methylprednisolone
6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
83-43-2
AC1L1N7A
Artisone-Wyeth
Artisone-wyeth
BPBio1_000174
BRD-K35240538-001-03-1
BRN 2340300
BSPBio_000158
Besonia
Bio-0658
CHEBI:6888
CHEMBL650
CID6741
CPD000058330
D00407
D008775
DB00959
Depo-Medrol (acetate)
Dopomedrol
EINECS 201-476-4
Esametone
Firmacort
HMS1568H20
HMS2090B13
HSDB 3127
LMST02030178
LS-118498
Lemod
M0639_SIGMA
M1665
MEPRDL
MLS000028541
MLS001148159
MLS002207191
Medesone
Medixon
Medlone 21
 
Medrate
Medrol
Medrol (TN)
Medrol Adt Pak
Medrol Dosepak
Medrol adt pak
Medrol dosepak
Medrol, Solu-Medrol, Medrone, Methylprednisolone
Medrone
Mesopren
Metastab
Methyleneprednisolone
Methylprednisolon
Methylprednisolone
Methylprednisolone (JP15/USP/INN)
Methylprednisolone [USAN:INN:BAN:JAN]
Methylprednisolone, 6-alpha
Methylprednisolonum
Methylprednisolonum [INN-Latin]
Metilbetasone
Metilprednisolona
Metilprednisolona [INN-Spanish]
Metilprednisolone
Metilprednisolone [DCIT]
Metilprednisolone [Dcit]
Metipred
Metrisone
Metrocort
Metysolon
Moderin
MolPort-002-528-554
NCGC00022735-03
NCI60_001657
NSC-19987
NSC19987
Nirypan
Noretona
Predni N Tablinen
Prednol- L
Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI)
Prestwick0_000279
Prestwick1_000279
Prestwick2_000279
Prestwick3_000279
Prestwick_622
Promacortine
Reactenol
S1733_Selleck
SAM002589984
SMR000058330
SPBio_002377
Sieropresol
Solomet
Summicort
Suprametil
U 7532
UNII-X4W7ZR7023
Urbason
Urbasone
Wyacort
ZINC03875560
delta(1)-6alpha-Methylhydrocortisone
delta(sup 1)-6-alpha-Methylhydrocortisone
methylprednisolone
methylprenisolone
3
AcetylcholineapprovedPhase 480551-84-3187
Synonyms:
ACh
Acetyl choline ion
Acetylcholine Chloride
Acetylcholine cation
 
Acetylcholinium: acetyl-Choline
Choline acetate
Choline acetate (ester)
O-Acetylcholine
acetylcholine chloride
4
Lidocaineapproved, vet_approvedPhase 41317137-58-63676
Synonyms:
.alpha.-(Diethylamino)-2,6-acetoxylidide
.alpha.-Diethylamino-2,6-dimethylacetanilide
.alpha.-Diethylaminoaceto-2,6-xylidide
.omega.-Diethylamino-2,6-dimethylacetanilide
137-58-6
2-(Diethylamino)-2',6'-acetoxylidide
2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide
2-Diethylamino-N-(2,6-dimethyl-phenyl)-acetamide
2-Diethylamino-N-(2,6-dimethylphenyl)acetamide
4-12-00-02538 (Beilstein Handbook Reference)
6108-05-0 (MONOHYDROCHLORIDE MONOHYDRATE))
6108-05-0 (mono-hydrochloride, mono-hydrate)
73-78-9 (mono-hydrochloride)
AB00053581
AC-10282
AC1L1GGQ
AC1Q2Z7J
AKOS001026768
ARONIS23855
After Burn Double Strength Gel
After Burn Double Strength Spray
After Burn Gel
After Burn Spray
Alphacaine
Anestacon
Anestacon Jelly
BIDD:GT0342
BPBio1_000197
BRD-K52662033-001-02-6
BRD-K52662033-003-05-5
BRN 2215784
BSPBio_000179
BSPBio_001359
BSPBio_003004
Bio-0767
Bio1_000379
Bio1_000868
Bio1_001357
Bio2_000079
Bio2_000559
C07073
C14H22N2O
CAS-73-78-9
CDS1_000283
CHEBI:6456
CHEMBL79
CID3676
CPD000058189
Cappicaine
Cito optadren
Cuivasil
D00358
DB00281
Dalcaine
Dentipatch
Dentipatch (TN)
DermaFlex
Diethylaminoaceto-2,6-xylidide
Dilocaine
DivK1c_000174
DivK1c_001323
Duncaine
EINECS 205-302-8
ELA-Max
EMBOLEX
Emla
Emla Cream
Esracaine
FT-0082378
Gravocain
HMS1791D21
HMS1989D21
HMS2051C21
HMS2089E15
HMS548M19
HSDB 3350
I01-2704
IDI1_000174
IDI1_033829
Isicaina
Isicaine
Jetocaine
KBio1_000174
KBio2_000079
KBio2_001598
KBio2_002647
KBio2_004166
KBio2_005215
KBio2_006734
KBio3_000157
KBio3_000158
KBio3_002224
KBioGR_000079
KBioGR_000599
KBioSS_000079
KBioSS_001598
L-Caine
L0156
L1026_SIGMA
L7757_SIGMA
LIDOCAINE (73-58-6 (MONOHYDROCHLORIDE)
LIDOPEN
LQZ
 
LS-805
Lanabiotic
Leostesin
Lida-Mantle
Lidocaina
Lidocaina [INN-Spanish]
Lidocaine (JP15/USP/INN)
Lidocaine (VAN)
Lidocaine Carbonate
Lidocaine Hydrocarbonate
Lidocaine Monohydrochloride
Lidocaine [USAN:INN:JAN]
Lidocainum
Lidocainum [INN-Latin]
Lidocaton
Lidoderm
Lidoject-1
Lidoject-2
Lignocaine
Lignocainum
Lingocaine
Lopac-L-5647
Lopac0_000669
MLS000069724
MLS000758263
MLS001074177
Maricaine
Maybridge1_002571
MolPort-001-783-478
N-(2,6-dimethylphenyl)-N(2),N(2)-diethylglycinamide
N-(2,6-dimethylphenyl)-N~2~,N~2~-diethylglycinamide
NCGC00015611-01
NCGC00015611-02
NCGC00015611-03
NCGC00015611-04
NCGC00015611-14
NCGC00022176-05
NCGC00022176-06
NCGC00022176-07
NCGC00022176-08
NCGC00022176-09
NINDS_000174
NSC 40030
NSC40030
Norwood Sunburn Spray
Octocaine
Octocaine-100
Octocaine-50
Prestwick0_000050
Prestwick1_000050
Prestwick2_000050
Prestwick3_000050
Remicaine
Rocephin Kit
Rucaina
S1357_Selleck
SAM001247018
SMR000058189
SPBio_001525
SPBio_002100
STK552033
Solarcaine
Solarcaine aloe extra burn relief cream
Solcain
Spectrum2_001343
Spectrum3_001392
Spectrum4_000070
Spectrum5_001549
Spectrum_001118
UNII-98PI200987
WLN: 2N2 & 1VMR B1 F1
Xilina
Xilocaina
Xilocaina [Italian]
Xllina
Xycaine
Xylestesin
Xylesthesin
Xylocain
Xylocaine
Xylocaine (TN)
Xylocaine 5% Spinal
Xylocaine CO2
Xylocaine Dental Ointment
Xylocaine Endotracheal
Xylocaine Test Dose
Xylocaine Viscous
Xylocaine-MPF
Xylocaine-MPF with Glucose
Xylocaine-Mpf
Xylocaine-Mpf with Glucose
Xylocard
Xylocitin
Xyloneural (free base)
Xylotox
Zilactin-L
Zingo
alfa-Dietilamino-2,6-dimetilacetanilide
alfa-Dietilamino-2,6-dimetilacetanilide [Italian]
alpha-Diethylamino-2,6-dimethylacetanilide
alpha-diethylamino-2,6-dimethylacetanilide
lidocaine
nchembio.65-comp16
α-diethylamino-2,6-dimethylacetanilide
5Peripheral Nervous System AgentsPhase 4, Phase 323689
6Methylprednisolone HemisuccinatePhase 4, Phase 31193
7Neuroprotective AgentsPhase 4, Phase 31716
8Prednisolone hemisuccinatePhase 4, Phase 31193
9Protective AgentsPhase 4, Phase 37443
10Prednisolone phosphatePhase 4, Phase 31193
11Prednisolone acetatePhase 4, Phase 31193
12Methylprednisolone acetatePhase 4, Phase 31193
13Autonomic AgentsPhase 4, Phase 310150
14Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 4, Phase 313168
15Antineoplastic Agents, HormonalPhase 4, Phase 35592
16Anti-Inflammatory AgentsPhase 4, Phase 310729
17AntiemeticsPhase 4, Phase 34022
18Gastrointestinal AgentsPhase 4, Phase 38402
19glucocorticoidsPhase 4, Phase 35103
20HormonesPhase 4, Phase 314415
21Hormone AntagonistsPhase 4, Phase 313180
22Neuromuscular AgentsPhase 41180
23incobotulinumtoxinAPhase 4662
24VaccinesPhase 4, Phase 36611
25Cholinergic AgentsPhase 43992
26onabotulinumtoxinAPhase 4652
27Neurotransmitter AgentsPhase 418340
28Botulinum ToxinsPhase 4697
29Botulinum Toxins, Type APhase 4657
30Anti-Infective AgentsPhase 4, Phase 322062
31Antiviral AgentsPhase 49967
32valacyclovirPhase 4106
33AcyclovirPhase 4183
34abobotulinumtoxinAPhase 4652
35Diuretics, Potassium SparingPhase 41917
36Central Nervous System DepressantsPhase 413403
37Sodium Channel BlockersPhase 41593
38Anti-Arrhythmia AgentsPhase 43093
39AnestheticsPhase 49596
40Anesthetics, LocalPhase 43492
41Respiratory System AgentsPhase 34997
42Pulmonary SurfactantsPhase 3111
43
ImidaclopridPhase 2187105827-78-986418
Synonyms:
(e)-imidacloprid
(z)-imidacloprid
1-((6-Chloro-3-pyridyl)methyl)-N-nitro-2-imidazolidinimine
1-(2-Chloro-5-pyridylmethyl)-2-(nitroimino)imidazolidine
1-[(6-Chloro-3-pyridinyl)methyl]-4,5-dihydro-N-nitro-1H-imidazol-2-amine, 9CI
Admire
Advantage
Advantage flea adulticide
Bayer brand of imidacloprid
 
Confidor
Confidor 200 SL
Confidor SL
Gaucho
Imidacloprid (old RN)
Imidacloprid [iso]
Merit
Merit (insecticide)
Premise 75
Provado
44alpha-methyltyrosinePhase 26
45
Prednisoneapproved, vet_approved139853-03-25865
Synonyms:
(1S,2R,10S,11S,14R,15S)-14-hydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-diene-5,17-dione
(8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione
(8xi,9xi,14xi)-17,21-dihydroxypregna-1,4-diene-3,11,20-trione
.delta. E
.delta.(sup1)-Cortisone
.delta.-Cortelan
.delta.-Cortisone
.delta.-Cortone
.delta.-E
.delta.1-Cortisone
.delta.1-Dehydrocortisone
.delta.sone
1,2-Dehydrocortisone
1,4-Pregnadiene-17-alpha,21-diol-3,11,20-trione
1,4-Pregnadiene-17.alpha.,21-diol-3,11,20-trione
1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione
1-Cortisone
1-Dehydrocortisone
17,21-Dihydroxypregna-1,4-diene-3,11,20-trione
17alpha,21-Dihydroxy-1,4-pregnadiene-3,11,20-trione
53-03-2
68-59-7
81552_FLUKA
AC-11112
AC1L1LB2
AC1Q29EZ
ACon0_000082
ACon1_000297
AI3-52939
Adasone
Ancortone
Apo-Prednisone
Apo-prednisone
BPBio1_000323
BRD-K85883481-001-04-2
BSPBio_000293
Betapar
Bicortone
Bio-0649
C07370
C21H26O5
CCRIS 2646
CHEBI:8382
CHEMBL635
CID5865
CPD001227202
Cartancyl
Colisone
Cortan
Cortancyl
Cortidelt
Cotone
DB00635
Dacorten
Dacortin
Decortancyl
Decortin
Decortisyl
Dehydrocortisone
Dekortin
Delcortin
Dellacort
Dellacort A
Delta Cortelan
Delta E
Delta E.
Delta-Cortelan
Delta-Dome
Delta-cortelan
Delta-cortisone
Delta-cortone
Delta-dome
Deltacortene
Deltacortisone
Deltacortone
Deltasone
Deltasone, Liquid Pred, Orasone, Adasone, Deltacortisone,Prednisone
Deltison
Deltisona
Deltisone
Deltra
Di-Adreson
Diadreson
EINECS 200-160-3
Econosone
Encorton
Encortone
Enkortolon
Enkorton
Fernisone
Fiasone
HMS1568O15
HMS2090J13
HSDB 3168
Hostacortin
In-Sone
Incocortyl
 
Juvason
Kortancyl
LMST02030180
LS-1325
Liquid Pred
Lisacort
Lodotra
MEGxm0_000443
MLS001061265
MLS001304073
MLS001335907
MLS001335908
MLS002154191
MLS002207083
Me-Korti
Metacortandracin
Meticorten
Meticorten (Veterinary)
Metrevet (Veterinary)
MolPort-001-740-041
NCGC00090766-01
NCGC00090766-02
NCGC00090766-03
NCI-C04897
NCI60_000008
NSC 10023
NSC10023
Nisona
Nizon
Novoprednisone
Nurison
Orasone
Origen Prednisone
P1276
P6254_SIGMA
PRD
Panafcort
Panasol
Paracort
Parmenison
Pehacort
Precort
Predeltin
Prednicen-M
Prednicorm
Prednicort
Prednicot
Prednidib
Prednilonga
Prednison
Prednisona
Prednisona [INN-Spanish]
Prednisone
Prednisone Intensol
Prednisone [INN:BAN]
Prednisonum
Prednisonum [INN-Latin]
Prednitone
Prednizon
Prednovister
Presone
Prestwick0_000077
Prestwick1_000077
Prestwick2_000077
Prestwick3_000077
Prestwick_405
Pronison
Pronisone
Rectodelt
Retrocortine
S1622_Selleck
SAM002264641
SK-Prednisone
SMR000718760
SMR001227202
SPBio_002214
Servisone
Sone
Sterapred
Supercortil
U 6020
UNII-VB0R961HZT
Ultracorten
Ultracortene
WLN: L E5 B666 CV OV AHTTT&J A1 E1 FV1Q FQ
Winpred
Wojtab
ZINC03875357
Zenadrid
Zenadrid (veterinary)
Zenadrid [veterinary]
delta cortelan
delta(sup 1)-Cortisone
delta(sup 1)-Dehydrocortisone
delta-1-Cortisone
delta-1-Dehydrocortisone
delta-Cortisone
delta-Cortone
46
Miconazoleapproved, investigational, vet_approved370622916-47-84189
Synonyms:
(+-)-1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole
1-[2,4-Dichloro- beta-([2,4-dichloro- benzyl]oxy)phenethyl]imidazole
1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole
1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole
1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole
1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole
1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole
1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole
22832-87-7 (NITRATE)
22916-47-8
75319-47-0
AB00053500
AC1L1HM1
AKOS001574474
Aflorix(nitrate)
Albistat(nitrate)
Andergin(nitrate)
BPBio1_000279
BRD-A82396632-001-03-0
BRD-A82396632-008-02-7
BRN 0965511
BSPBio_000253
BSPBio_002033
CCRIS 7924
CHEBI:6923
CHEMBL91
CID4189
CPD-4501
Conofite(nitrate)
D00416
DB01110
Dactarin
Daktarin IV
Daktarin iv
DivK1c_000156
EINECS 245-324-5
Epi-Monistat(nitrate)
Femizol-M
Florid(nitrate)
Gyno-Daktar(nitrate)
HMS1568M15
HMS2090B21
I14-14342
IDI1_000156
Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)- (9CI)
KBio1_000156
KBio2_001445
KBio2_004013
KBio2_006581
KBio3_001533
KBioGR_000581
KBioSS_001445
LS-78378
Lotrimin AF(nitrate)
MCZ
MJR 1762
MLS002222203
Micantin (nitrate)
Miconasil Nitrate
 
Miconazol
Miconazol [INN-Spanish]
Miconazole
Miconazole (JP15/USP/INN)
Miconazole 3
Miconazole 3 Combination Pack
Miconazole 7 Combination Pack
Miconazole [USAN:BAN:INN:JAN]
Miconazole nitrate salt
Miconazole-7
Miconazolo
Miconazolo [DCIT]
Miconazolum
Miconazolum [INN-Latin]
Micozole
Minostate
MolPort-002-557-553
Monazole 7
Monista (nitrate)
Monistat
Monistat (TN)
Monistat 1 Combination Pack
Monistat 3 Dual-Pak
Monistat 3 Vaginal Ovules
Monistat 5 Tampon
Monistat 7 Dual-Pak
Monistat 7 Vaginal Suppositories
Monistat Dual- PAK
Monistat IV
Monistat iv (TN)
Monistat iv (tn)
Monistat-Derm
NCI60_001353
NCI60_001380
NINDS_000156
NSC 170986
NSC169434
NSC170986
Novo-Miconazole Vaginal Ovules
Oprea1_091955
Prestwick0_000067
Prestwick1_000067
Prestwick2_000067
Prestwick3_000067
Prestwick_335
R 18134
R-14,889
SMR001307249
SPBio_000976
SPBio_002174
STK834405
STOCK1S-93556
Spectrum2_001048
Spectrum3_000507
Spectrum4_000061
Spectrum5_001297
Spectrum_000965
UNII-7NNO0D7S5M
Vusion
Zimycan
imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)- (9CI)
miconazole
47
Salicylic acidapproved, vet_approved18969-72-7338
Synonyms:
105910_ALDRICH
105910_SIAL
2 Hydroxybenzoic Acid
2-Carboxyphenol
2-Hydroxybenzenecarboxylate
2-Hydroxybenzenecarboxylic acid
2-Hydroxybenzoate
2-Hydroxybenzoic acid
2-hydroxy(1-14c)benzoic acid
247588_SIAL
27301_SIAL
69-72-7
7681-06-3
8052-31-1
84210_FLUKA
84210_SIAL
AB1002436
AC1L190M
AC1Q1HCK
AC1Q72IF
AI3-02407
AKOS000118979
ALPHA/BETA HYDROXY ACIDS (SALICYLIC ACID) (SEE ALPHA/BETA HYDROXY ACIDS)
AR-1E2203
ATA fraction 10, ammonium salt
Acid, 2-Hydroxybenzoic
Acid, Salicylic
Acid, o-Hydroxybenzoic
Acid, ortho-Hydroxybenzoic
Acido o-idrossibenzoico
Acido o-idrossibenzoico [Italian]
Acido salicilico
Acido salicilico [Italian]
Acidum salicylicum
Advanced Pain Relief Callus Removers
Advanced Pain Relief Corn Removers
Advanced pain relief callus removers
Advanced pain relief corn removers
Akurza Cream
Akurza Lotion
Alpha/Beta Hydroxy Acids (Glycolic Acid, Salicylic Acid)
BENZOIC ACID,2-HYDROXY SALICYLIC ACID
BIDD:ER0602
BRN 0774890
Benzoic acid, 2-hydroxy- (9CI)
C00805
CCRIS 6714
CHEBI:16914
CHEMBL424
CID338
CMC_13852
Caswell No. 731
Clear away Wart Remover
Clear away wart remover
Compound W
Compound w
D00097
D020156
DB00936
DHS Sal Shampoo
DivK1c_000301
Domerine
Dr. Scholl'S Callus Removers
Dr. Scholl'S Corn Removers
Dr. Scholl'S Wart Remover Kit
Dr. Scholl's callus removers
Dr. Scholl's corn removers
Dr. Scholl's wart remover kit
DuoPlant Gel
Duofil Wart Remover
Duofil wart remover
Duofilm
Duoplant
E9A559BE-383B-4F83-BC02-3031D03D558A
EINECS 200-712-3
EPA Pesticide Chemical Code 076602
Freezone
H0206
HSDB 672
Hydrisalic Gel
I04-0192
IDI1_000301
InChI=1/C7H6O3/c8-6-4-2-1-3-5(6)7(9)10/h1-4,8H,(H,9,10
Ionil
Ionil Plus
Ionil plus
Ionil-Plus
 
K 537
K 557
KBio1_000301
KBio2_001428
KBio2_003996
KBio2_006564
KBioSS_001428
Keralyt
Kyselina 2-hydroxybenzoova
Kyselina 2-hydroxybenzoova [Czech]
Kyselina salicylova
Kyselina salicylova [Czech]
LS-2169
MLS000069653
Mediplast pads
MolPort-001-769-476
NCGC00159447-02
NCGC00159447-04
NINDS_000301
NSC 180
NSC180
NSC629474
O-Carboxyphenol
O-Hydroxybenzoate
O-Hydroxybenzoic acid
O-carboxyphenol
O-hydroxybenzoic acid
Occlusal
Oprea1_040343
Orthohydroxybenzoic acid
P&S Shampoo
Phenol-2-carboxylate
Phenol-2-carboxylic acid
Propa pH Peel-Off Acne Mask
Psoriacid-S-Stift
Psoriacid-S-stift
Retarder SAX
Retarder W
Rutranex
S5922_SIGMA
S7401_SIGMA
S8519_SIGMA
SALICYLIC ACID (SEE ALSO ALPHA HYDROXY ACIDS)
SALICYLIC ACID, ACS
SAX
SBB052826
SGCUT00012
SMP2_000145
SMR000059163
STK258681
Salex Cream
Salex Lotion
Salicyclic acid
Salicylate
Salicylic acid
Salicylic acid & Sulfur Soap
Salicylic acid (6CI,8CI)
Salicylic acid (JP15/USP)
Salicylic acid (TN)
Salicylic acid Soap
Salicylic acid [USAN:JAN]
Salicylic acid collodion
Salicylic acid soap
Salicylic acid, tech
Salicylic acid, tech.
Salicylic acid-ring-UL-14C
Saligel
Salonil
Sebucare
Sebulex
Spectrum_000948
Stri-Dex
Trans-Ver-Sal
UNII-O414PZ4LPZ
UPCMLD-DP126
UPCMLD-DP126:001
Verrugon
W398500_ALDRICH
WLN: QVR BQ
bmse000252
o Hydroxybenzoic Acid
o-Carboxyphenol
o-hydroxybenzoic acid
ortho Hydroxybenzoic Acid
ortho-Hydroxybenzoic Acid
phenol derivative, 7
salicylate
salicylic acid
to_000004
48
MentholapprovedEarly Phase 126062216-51-516666
Synonyms:
(−
()-Menthol
(+)-Neo-menthol
(+)-p-Menthan-3-ol
(+-)-(1R*,3R*,4S*)-Menthol
(+-)-Menthol
(+/-)-Menthol
(+/-)-p-Menthan-3-ol
(-)-(1R,3R,4S)-Menthol
(-)-Menthyl alcohol
(-)-menthol
(-)-p-Menthan-3-ol
(-)-trans-p-Menthan-cis-ol
(1R)-(-)-Menthol
(1R,2S,5R)-(-)-menthol
(1R,2S,5R)-Menthol
(1R,3R,4S)-(-)-MENTHOL
(1R,3R,4S)-(-)-Menthol
(1R-(1-alpha,2-beta,5-alpha))-5-Methyl-2-(1-methylethyl)cyclohexanol
(1S, 2S, 5R)-(+)-Neomenthol
(1S,2R,5R)-(+)-Isomenthol
(1S,2R,5S)-(+)-Menthol
(1S,2R,5S)-Menthol
(1alpha,2beta,5alpha)-5-Methyl-2(1-methylethyl)cyclohexanol
(1r,2s,5r)-(-)-menthol
(L)-MENTHOL
(R)-(-)-Menthol
(r)-(-)-menthol
)-Menthol
--MENTHOL
1-Menthol
1490-04-6
15356-60-2
15356-70-4
15785_RIEDEL
15785_SIAL
19863P
2-Isopropyl-5-methylcyclohexanol
20747-49-3
2216-51-5
3-p-Menthol
4-Isopropyl-1-methylcyclohexan-3-ol
491-02-1
5-Methyl-2-(1-methylethyl)-cyclohexanol
5-Methyl-2-(1-methylethyl)cyclohexanol
5-methyl-2-(propan-2-yl)cyclohexanol
5-methyl-2-propan-2-ylcyclohexan-1-ol
551376_ALDRICH
551376_FLUKA
588733_ALDRICH
613290_ALDRICH
613290_FLUKA
63660_FLUKA
63670_ALDRICH
63670_FLUKA
63975-60-0
6C6A4A8C-A054-468C-A1F0-F29E39838CF2
89-78-1
98167-53-4
AC1L1B2E
AC1L28FR
AC1Q1NQ2
AC1Q2QQM
AI3-08161
AI3-52408
AKOS000119740
AR-1J3337
BB_NC-0057
BRN 1902288
BRN 3194263
BSPBio_003062
C00400
C10H20O
CCRIS 3728
CCRIS 375
CCRIS 4666
CCRIS 9231
CHEBI:15409
CHEBI:545611
CHEMBL256087
CHEMBL470670
CID1254
CID16666
Caswell No. 540
D-(-)-Menthol
D-p-Menthan-3-ol
D00064
D008610
D04849
D04918
DB00825
DivK1c_000820
EINECS 201-939-0
EINECS 207-724-8
EINECS 216-074-4
EINECS 218-690-9
EINECS 239-387-8
EINECS 239-388-3
EPA Pesticide Chemical Code 051601
FEMA No. 2665
Fisherman's friend lozenges
Fisherman's friend lozenges (TN)
HMS1922G13
HMS2092L14
HMS502I22
 
HSDB 5662
HSDB 593
Headache crystals
Hexahydrothymol
I06-1216
I14-7371
IDI1_000820
KBio1_000820
KBio2_000785
KBio2_003353
KBio2_005921
KBio3_002562
KBioSS_000785
L-(-)-Menthol
L-(-)-menthol
L-Menthol
L-menthol
LMPR0102090001
LS-2353
LS-57201
LS-886
LS-89531
LS-89533
Levomenthol
Levomenthol [INN:BAN]
Levomentholum
Levomentholum [INN-Latin]
Levomentol
M0321
M0545
M2772_SIAL
MENTHOL
MLS002207256
Menthacamphor
Menthol
Menthol (USP)
Menthol (VAN)
Menthol natural
Menthol natural, brazilian
Menthol racemic
Menthol racemique
Menthol racemique [French]
Menthol solution
Menthol, (1alpha,2beta,5alpha)-Isomer
Menthomenthol
Menthyl alcohol
MolPort-000-849-729
MolPort-001-793-392
NCGC00159382-02
NCGC00159382-03
NCGC00164247-01
NCGC00164247-02
NCI-C50000
NINDS_000820
NOOLISFMXDJSKH-KXUCPTDWBX
NSC 2603
NSC 62788
NSC2603
NSC62788
Neoisomenthol
Peppermint camphor
RACEMIC MENTHOL U.S.P.
Racementhol
Racementhol [INN:BAN]
Racementholum
Racementholum [INN-Latin]
Racementol
Racementol [INN-Spanish]
Racemic menthol
Robitussin Cough Drops
SDCCGMLS-0066659.P001
SMR001306785
SPBio_000869
SPECTRUM1503134
STK802468
Spectrum2_000855
Spectrum3_001561
Spectrum5_001060
Spectrum_000305
Tra-kill tracheal mite killer
U.S.P. Menthol
U.S.p. Menthol
UNII-BZ1R15MTK7
UNII-L7T10EIP3A
UNII-YS08XHA860
W266507_ALDRICH
W266523_ALDRICH
W266590_ALDRICH
WLN: L6TJ AY1&1 BQ D1
WLN: L6TJ AY1&1 DQ D1 -L
ZINC01482164
cis-1 ,3-trans-1,4-(+-)-menthol
cis-1,3-trans-1,4-(+-)-menthol
d,l-Menthol
d-Menthol
d-Neomenthol
dl-3-p-Menthanol
dl-Menthol
dl-Menthol (JP15)
l-(-)-Menthol
l-Menthol
l-Menthol (JP15)
l-Menthol (TN)
l-Menthol (natural)
nchembio862-comp1
p-Menthan-3-ol
rac-Menthol
49Keratolytic Agents444
50Antifungal Agents3696

Interventional clinical trials:

(show all 44)
idNameStatusNCT IDPhase
1Scandinavian Bell's Palsy StudyCompletedNCT00510263Phase 4
2Comparison of Three Botulinum Neuromodulators for Management of Facial SynkinesisCompletedNCT03048383Phase 4
3Postmarketing Safety Study of Q/LAIV in Subjects 2 Through 49 Years of AgeCompletedNCT01985997Phase 4
4Reinnervation of Facial Muscles After Lengthening Temporalis MyoplastyTerminatedNCT01833221Phase 4
5Corticosteroids in Prevention of Facial Palsy After Cranial Base SurgeryCompletedNCT00438087Phase 3
6Additional 6-Month Safety Follow-up After Completion of Precursor Study 880801CompletedNCT01604746Phase 3
7Transfusion of Prematures TrialRecruitingNCT01702805Phase 3
8Surfactant Positive Airway Pressure and Pulse Oximetry TrialActive, not recruitingNCT00233324Phase 3
9Darbepoetin Trial to Improve Red Cell Mass and Neuroprotection in Preterm InfantsNot yet recruitingNCT03169881Phase 3
10Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)TerminatedNCT01192776Phase 3
11Quadrant Versus Superficial ParotidectomyWithdrawnNCT01607866Phase 2, Phase 3
12Comparison of Antibiotic Therapy Alone or Combined With Corticosteroids for the Treatment of Nontuberculous Mycobacterial Cervicofacial Lymphadenitis in Children: A Randomized Double-Blind Placebo-Controlled StudyWithdrawnNCT01614977Phase 3
13Benefits of Applying Neuroprosthesis to Improve Grasping and Reaching in Spinal Cord Injury PatientsCompletedNCT00221117Phase 2
14Metyrosine (Demser®) for the Treatment of Psychotic Disorders in Patients With Velocardiofacial SyndromeTerminatedNCT01127503Phase 2
15The Relationship Between Psychological Factors and Bell's PalsyUnknown statusNCT01377766
16Prednisone and Acupuncture for the Treatment of Facial Neuritis: a Multiple Center, CER in ChinaUnknown statusNCT01201642
17A Clinical Study on the Combined Magnetic and Oxygen Treatment for Bell's PalsyCompletedNCT01686464
18Acupuncture With Deqi And Psychological Effects in Treatment of Bell's PalsyCompletedNCT00685789
19Randomized Controlled Trial of Acupuncture to Treat Bell's Palsy According to Different StagesCompletedNCT00608660
20Prednisone-Placebo vs Prednisone-Valacyclovir in Bell´s PalsyCompletedNCT00561106
21Steroid-Antiviral Treatment in Rehabilitation of Facial PalsyCompletedNCT02328079
22Microbiologic Findings of Acute Facial Palsy in ChildrenCompletedNCT01537952
23Anthropometric Angular Measurement to Determine Muscle Tonus in Patients With Peripheral Facial ParalysisCompletedNCT00903669
24Myofunctional Therapy in Facial PalsyCompletedNCT00989209
25Assessment of the Cross-face Nerve Graft in the Treatment of Facial ParalysisCompletedNCT03006783
26Cognitive Function and Emotional Possessing in Bilateral Facial PalsyCompletedNCT02179450
27Study of a New Technique to Improve the Symptoms of Orofacial Discomfort in Patients With Peripheral Facial ParalysisCompletedNCT01327157
28Complications in Parotid SurgeryCompletedNCT02486393
29Retrospective Clinical Outcome of Parotid Tumor SurgeryCompletedNCT01983176
30Post-parotidectomy Facial Paresis: Intraoperative and Postoperative FactorsCompletedNCT02527226
31Clinical Research Core Dental Screening ProtocolCompletedNCT00090818
32Ultrasound Evaluation of Tongue Movements in Speech and SwallowingCompletedNCT00001167
33Morphometric Study of the Muscles of the Skin in MRI 3 Tesla in Patients With Facial Paralysis.RecruitingNCT03115203
34The Role of a Device to Evaluate the Neuromuscular Function in Assessing Muscle in Facial Paralysis PatientsRecruitingNCT02489162
35The Prehospital Selection of Acute Stroke PatientsRecruitingNCT03072524
36Quantification, Analysis and Simulation of Facial Mimics MovementsRecruitingNCT02002572
37R. I. S. POS. T. ARecruitingNCT01991665
38A Multicenter Study to Evaluate a Borrelia Diagnostic Test in Subjects With Early Stage or Late Stage Lyme DiseaseRecruitingNCT02741609
39Genetic Studies of Strabismus, Congenital Cranial Dysinnervation Disorders (CCDDs), and Their Associated AnomaliesRecruitingNCT03059420
40Acute Nerve Decompression Versus Non-operative Treatment for Peroneal Nerve Palsy Following Primary Total Knee ArthroplastyRecruitingNCT02856958
41Magnetic Correction of Eye Lid ParalysisActive, not recruitingNCT02988856
42Surgery or Clincial Follow up, in Patients With Bell' s PalsyEnrolling by invitationNCT02179684
43Virtual Rehabilitation Program in Peripheral Facial ParalysisNot yet recruitingNCT02892864
44Two Different Surgical Methods of BlepharospasmNot yet recruitingNCT02765113Early Phase 1

Search NIH Clinical Center for Bell's Palsy

Inferred drug relations via UMLS68/NDF-RT46:


Cochrane evidence based reviews: bell palsy

Genetic Tests for Bell's Palsy

About this section

Anatomical Context for Bell's Palsy

About this section

MalaCards organs/tissues related to Bell's Palsy:

36
Eye, Testes, Neutrophil, Cortex, Brain, Cingulate cortex, T cells

Publications for Bell's Palsy

About this section

Articles related to Bell's Palsy:

(show top 50)    (show all 599)
idTitleAuthorsYear
1
Erratum to: Association Between Statin Use and Bell's Palsy: A Population-Based Study. (28083785)
2017
2
Benefits of High-dose Steroida88+a88Hespandera88+a88Mannitol Administration in the Treatment of Bell's Palsy. (28068304)
2017
3
Prognostic factors of Bell's palsy and Ramsay Hunt syndrome. (28079835)
2017
4
Diagnostic and prognostic value of procalcitonin levels in patients with Bell's palsy. (26894418)
2016
5
Steroid/Antiviral for the treatment of Bell's palsy: Double blind randomized clinical trial. (27689547)
2016
6
Thiol/disulphide homeostasis in Bell's palsy as a novel pathogenetic marker. (27383276)
2016
7
Efficacy of Low-Dose Corticosteroid Therapy Versus High-Dose Corticosteroid Therapy in Bell's Palsy in Children. (27686096)
2016
8
Erratum to: Comparison of acyclovir and famciclovir for the treatment of Bell's palsy. (27501992)
2016
9
Bell's palsy. (27344096)
2016
10
Rhinoscintigraphic analysis of nasal mucociliary function in patients with Bell's palsy. (27022800)
2016
11
Bell's palsy at high altitude -- an unsuspected finding. (27182447)
2016
12
Needle Sensation and Personality Factors Influence Therapeutic Effect of Acupuncture for Treating Bell's Palsy: A Secondary Analysis of a Multicenter Randomized Controlled Trial. (27453226)
2016
13
Do Antiviral Medications Improve Symptoms in the Treatment of Bell's Palsy? (27350020)
2016
14
Corticosteroids for Bell's palsy (idiopathic facial paralysis). (27428352)
2016
15
Comparison of acyclovir and famciclovir for the treatment of Bell's palsy. (26873601)
2016
16
The role of facial canal diameter in pathogenesis and grade of Bell's palsy: a study by high resolution computed tomography. (27217008)
2016
17
A Case of Bell's Palsy with an Incidental Finding of a Cerebellopontine Angle Lipoma. (27733958)
2016
18
Bell's palsy syndrome: mimics and chameleons. (27034243)
2016
19
Kabat rehabilitation for Bell's palsy in the elderly. (27967288)
2016
20
Functional Connectivity Modulation by Acupuncture in Patients with Bell's Palsy. (27293461)
2016
21
Role of Kabat rehabilitation in facial nerve palsy: a randomised study on severe cases of Bell's palsy. (27734980)
2016
22
Are corticosteroids useful in all degrees of severity and rapid recovery of Bell's palsy? (27003272)
2016
23
Letter to the Editor concerning "New Predictive Parameters of Bell's Palsy: Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio". (27994931)
2016
24
Help Desk Answers: Do corticosteroids relieve Bell's palsy? (27158696)
2016
25
Facial nerve palsy including Bell's palsy: Case definitions and guidelines for collection, analysis, and presentation of immunisation safety data. (27235092)
2016
26
Association between recovery from Bell's palsy and body mass index. (27886463)
2016
27
Infections in the differential diagnosis of Bell's palsy: a plea for performing CSF analysis. (27530390)
2016
28
Bell's Palsy. (26611696)
2016
29
Mandibular Canal Widening and Bell's Palsy: Sequelae of Perineural Invasion in Oral Cancer. (28025626)
2016
30
A general practice approach to Bell's palsy. (27806447)
2016
31
Ocular vestibular evoked myogenic potential testing for the prognosis of Bell's palsy. (27609665)
2016
32
The Effectiveness of Neural Therapy in Patients With Bell's Palsy. (27547166)
2016
33
Prevalence of Bell's palsy in Qena Governorate, Egypt. (27238882)
2016
34
Synkinesis in Bell's palsy in a randomised controlled trial. (27882653)
2016
35
Prognostic factors for recovery in Portuguese patients with Bell's palsy. (27426639)
2016
36
Neutrophil to lymphocyte ratio in Bell's palsy. (27368462)
2016
37
High-frequency ultrasound as an adjunct to neural electrophysiology: Evaluation and prognosis of Bell's palsy. (26889221)
2016
38
Antiviral treatment for Bell's palsy? (25907275)
2015
39
Delayed surgical management is not effective for severe Bell's palsy after two months of onset. (26514341)
2015
40
Reply to the Letter to the Editor: Intratympanic Steroid Injection for Bell's Palsy: Some Issues Highlighted. (26375983)
2015
41
Rehabilitation of Bell's palsy patient with complete dentures. (26538967)
2015
42
Involvement of MAPK ERK Activation in Upregulation of Water Channel Protein Aquaporin 1 in a Mouse Model of Bell's Palsy. (25527444)
2015
43
Guillain-BarrAc syndrome presenting as Bell's palsy with crossed hemiparesis. (25810972)
2015
44
Effects of Wind Chill Factor, Temperature and Other Meteorological Parameters on the Incidence of Bell's Palsy: Results Based on a Retrospective, 7-Year Long, Greek Population Study. (26227431)
2015
45
Antiviral treatment for Bell's palsy (idiopathic facial paralysis). (26517150)
2015
46
Bell's palsy in association with a cerebellar arachnoid cyst. (25878242)
2015
47
Prosthodontic Rehabilitation of Patients with Bell's Palsy: Our Experience. (26668488)
2015
48
Antiviral agents convey added benefit over steroids alone in Bell's palsy; decompression should be considered in patients who are not recovering. (25907276)
2015
49
Antiviral treatment for Bell's palsy (idiopathic facial paralysis). (26559436)
2015
50
New Predictive Parameters of Bell's Palsy: Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio. (26167340)
2015

Variations for Bell's Palsy

About this section

Expression for genes affiliated with Bell's Palsy

About this section
Search GEO for disease gene expression data for Bell's Palsy.

Pathways for genes affiliated with Bell's Palsy

About this section

Pathways related to Bell's Palsy according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
1
Show member pathways
9.6CD40LG, IL2RA
29.6CD40LG, IL2RA
39.6CD40LG, IL2RA

GO Terms for genes affiliated with Bell's Palsy

About this section

Biological processes related to Bell's Palsy according to GeneCards Suite gene sharing:

(show all 10)
idNameGO IDScoreTop Affiliating Genes
1antibacterial humoral responseGO:001973110.2DEFA1, DEFA3
2antimicrobial humoral responseGO:001973010.2DEFA1, DEFA3
3defense response to fungusGO:005083210.2DEFA1, DEFA3
4defense response to Gram-positive bacteriumGO:005083010.2DEFA1, DEFA3
5innate immune response in mucosaGO:000222710.1DEFA1, DEFA3
6intracellular estrogen receptor signaling pathwayGO:003052010.1DEFA1, DEFA3
7killing of cells of other organismGO:003164010.0DEFA1, DEFA3
8defense responseGO:00069529.8DEFA1, DEFA3, MX1
9defense response to virusGO:00516079.8DEFA1, DEFA3, MX1
10positive regulation of T cell proliferationGO:00421029.6CD40LG, IL2RA

Sources for Bell's Palsy

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet